Communication
Advanced
One Missing Detail Changed Everything
A patient’s partner urgently requested colchicine shortly before pharmacy closing time, stating that the patient was experiencing an “attack.” Due to the absence of a prescription and lack of dispensing history, supply was initially declined. A communication breakdown later revealed that the medication was required for Familial Mediterranean Fever (FMF), not gout. The case highlighted the importance of clarifying medical conditions, effective team communication, and reassessing clinical decisions when new information becomes available.
Clinical Focus
Updated
Reading Time
01 Patient Presentation
Approximately five minutes before pharmacy closing time, a woman presented with an empty bottle of colchicine and requested an urgent supply.
She explained that her partner was experiencing an “attack” and required the medication immediately. The patient was not known to the pharmacy, there was no dispensing history available, and no current prescription was provided.
The woman appeared distressed and repeatedly emphasized the urgency of the situation, stating that her partner was currently experiencing an attack.
02 Assessment
Initial assessment focused on the information available at the time.
Key factors identified were:
- No prescription available.
- No dispensing history accessible.
- Patient not registered with the pharmacy.
- Colchicine is a prescription-only medicine.
- The indication had not been clearly communicated.
Based on the information provided, the term “attack” was interpreted as a possible gout flare, which is a common indication for colchicine.
To provide symptomatic relief while remaining within professional boundaries, celecoxib (Celebrex®) was recommended as a temporary measure until a prescription could be obtained.
As the patient was leaving the pharmacy, further discussion revealed that the colchicine was being used for Familial Mediterranean Fever (FMF), a condition in which colchicine plays a critical role in disease management and prevention of complications.
This information significantly changed the clinical assessment.
03 Decision Made
Upon learning that the medication was required for FMF, the patient was immediately called back to the dispensary.
04 Action Taken
The earlier recommendation of celecoxib was withdrawn, as it would not adequately address the underlying condition or replace colchicine therapy.
After gathering additional information regarding the patient’s history and treatment, a limited emergency supply of seven colchicine tablets was provided to prevent interruption of therapy.
The patient was advised to obtain a valid prescription as soon as possible for ongoing treatment.
Detailed documentation was completed, and the incident was reported internally due to the communication issues involved
05 Reflection
This case demonstrated how easily clinical reasoning can be influenced by incomplete information.
At the time of the initial assessment, the information available suggested a possible gout flare, making symptomatic management appear reasonable. However, the later discovery that the patient had Familial Mediterranean Fever completely altered the clinical context.
The most important lesson was not related to pharmacology but communication.
The patient believed she had communicated the diagnosis, while the pharmacy team had not clearly received or recognised that information. Whether the diagnosis was not mentioned, not heard, or not effectively relayed between staff members remains uncertain. What became clear was that a critical piece of information failed to reach the decision-maker.
The case reinforced the importance of verifying indications directly with patients whenever possible, particularly when medications have multiple therapeutic uses.
It also highlighted the value of reassessing decisions when new information emerges. Once FMF was identified, the original management plan was immediately revised and a more appropriate solution was provided.
Although the interaction became emotionally charged and the patient remained dissatisfied, the experience strengthened my appreciation for thorough history-taking, team communication, and maintaining professionalism during difficult consultations.
Case Summary
A patient’s partner urgently requested colchicine shortly before pharmacy closing time, stating that the patient was experiencing an “attack.” Due to the absence of a prescription and lack of dispensing history, supply was initially declined. A communication breakdown later revealed that the medication was required for Familial Mediterranean Fever (FMF), not gout. The case highlighted the importance of clarifying medical conditions, effective team communication, and reassessing clinical decisions when new information becomes available.
Alternative Approach
Alternative actions could have included:
- Clarifying the indication before making any recommendations.
- Directly asking, “What condition is the colchicine used for?”
- Contacting the patient’s usual prescriber or pharmacy if time allowed.
- Escalating the request to a more detailed consultation immediately rather than relying on information passed through another staff member.
Earlier identification of FMF would likely have avoided patient frustration and prevented the initial recommendation of an alternative medicine.
Key Learning
A single missing detail can completely alter clinical decision-making. Pharmacists must clarify indications, particularly when medicines have multiple uses, and ensure critical information is communicated effectively between staff members.